Showing results (441-450 of 5,003) with videos related to
Sort By:
Pageof 501
American Journal of Clinical Oncology|October 1, 1989
Continuous intravenous infusion of 5-fluorouracil in the treatment of refractory breast cancerA Y Chang, C Most, K J PandyaAmerican Journal of Clinical Oncology|March 17, 2017
A Phase II Study of Ganetespib as Second-line or Third-line Therapy for Metastatic Pancreatic CancerDana B Cardin, Ramya Thota, Laura W Goff, et al.American Journal of Clinical Oncology|April 11, 2017
Concurrent Chemoradiotherapy in the Adjuvant Treatment of High-risk Primary Salivary Gland MalignanciesBrian J Gebhardt, James P Ohr, Robert L Ferris, et al.American Journal of Clinical Oncology|May 1, 2014
Efficacy and Tolerability of Palliative Split-Course Thoracic Chemoradiotherapy for Symptomatic Non-Small Cell Lung CancerVirag K Dandekar, Jennifer Young, Krystyna Kiel, et al.American Journal of Clinical Oncology|May 1, 2014
The Impact of Cancer on the Clinical Outcome of Patients After Inferior Vena Cava Filter Placement: A Retrospective Cohort StudyAnand Narayan, Kelvin Hong, Michael Streiff, et al.American Journal of Clinical Oncology|April 2, 2014
Intraoperative Radiation Therapy in the Management of Gynecologic MalignanciesOlivia W Foley, Jose A Rauh-Hain, Rachel M Clark, et al.American Journal of Clinical Oncology|April 2, 2014
Randomized Phase II Trial of Irinotecan/Docetaxel or Irinotecan/Docetaxel Plus Cetuximab for Metastatic Pancreatic Cancer: An Eastern Cooperative Oncology Group StudyBarbara Burtness, Mark Powell, Paul Catalano, et al.American Journal of Clinical Oncology|April 9, 2014
Factors Predictive of Improved Outcomes With Multimodality Local Therapy After Palliative Chemotherapy for Stage IV Esophageal CancerJingya Wang, Jaipreet S Suri, Pamela K Allen, et al.American Journal of Clinical Oncology|February 13, 2014
Phase II Trial of Target-guided Personalized Chemotherapy in First-line Metastatic Colorectal CancerAntonio Cubillo, Jesús Rodriguez-Pascual, Fernando López-Ríos, et al.American Journal of Clinical Oncology|April 1, 1988
Curative combination chemotherapy for patients with advanced poorly differentiated carcinoma of unknown primary siteJ D Hainsworth, T W Dial, F A GrecoPageof 501